Education
About Us
Working with TipRanks
Follow Us
Envoy Medical (COCH)
NASDAQ:COCH
Total Valuation
Envoy Medical has a market cap or net worth of $20.88M. The enterprise value is $53.91M.
Market Cap$20.88M
Enterprise Value$53.91M
Share Statistics
Envoy Medical has 28,786,510 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding28,786,510
Owned by Insiders37.01%
Owned by Institutions4.13%
Financial Efficiency
Envoy Medical’s return on equity (ROE) is 1.10 and return on invested capital (ROIC) is -464.78%.
Return on Equity (ROE)1.10
Return on Assets (ROA)-1.80
Return on Invested Capital (ROIC)-464.78%
Return on Capital Employed (ROCE)-4.81
Revenue Per Employee5.36K
Profits Per Employee-534.57K
Employee Count42
Asset Turnover0.02
Inventory Turnover0.43
Valuation Ratios
The current PE Ratio of Envoy Medical is ―. Envoy Medical’s PEG ratio is 0.03.
PE Ratio―
PS Ratio119.42
PB Ratio-1.43
Price to Fair Value-1.43
Price to FCF-1.42
Price to Operating Cash Flow-0.76
PEG Ratio0.03
Income Statement
In the last 12 months, Envoy Medical had revenue of 225.00K and earned -20.80M in profits. Earnings per share was -1.49.
Revenue225.00K
Gross Profit-517.00K
Operating Income-19.26M
Pretax Income-20.80M
Net Income-20.80M
EBITDA-19.81M
Earnings Per Share (EPS)-1.49
Cash Flow
In the last 12 months, operating cash flow was -16.90M and capital expenditures 527.00K, giving a free cash flow of -16.38M billion.
Operating Cash Flow-16.90M
Free Cash Flow-16.38M
Free Cash Flow per Share-0.57
Dividends & Yields
Envoy Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.08
52-Week Price Change-66.51%
50-Day Moving Average0.86
200-Day Moving Average1.30
Relative Strength Index (RSI)45.41
Average Volume (3m)5.78M
Important Dates
Envoy Medical upcoming earnings date is Apr 7, 2026, Before Open (Confirmed).
Last Earnings DateNov 10, 2025
Next Earnings DateApr 7, 2026
Ex-Dividend Date―
Financial Position
Envoy Medical as a current ratio of 1.24, with Debt / Equity ratio of -12.56%
Current Ratio1.24
Quick Ratio1.02
Debt to Market Cap0.70
Net Debt to EBITDA-0.72
Interest Coverage Ratio-23.60
Taxes
In the past 12 months, Envoy Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Envoy Medical EV to EBITDA ratio is -2.07, with an EV/FCF ratio of -2.17.
EV to Sales182.43
EV to EBITDA-2.07
EV to Free Cash Flow-2.17
EV to Operating Cash Flow-2.29
Balance Sheet
Envoy Medical has $3.56M in cash and marketable securities with $946.00K in debt, giving a net cash position of $2.61M billion.
Cash & Marketable Securities$3.56M
Total Debt$946.00K
Net Cash$2.61M
Net Cash Per Share$0.09
Tangible Book Value Per Share-$1.00
Margins
Gross margin is -216.83%, with operating margin of -8558.22%, and net profit margin of -9242.22%.
Gross Margin-216.83%
Operating Margin-8558.22%
Pretax Margin-9242.22%
Net Profit Margin-9242.22%
EBITDA Margin-8802.67%
EBIT Margin-8879.56%
Analyst Forecast
The average price target for Envoy Medical is $5.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$5.50
Price Target Upside663.89% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-25.18%
EPS Growth Forecast-9.71%